ledipasvir 33.75 MG / sofosbuvir 150 MG Oral Pellet [Harvoni]
RxNorm concept 2204102, branded drug (sbd). Prescribable name: Harvoni 33.75 MG / 150 MG per packet Oral Pellets.
- RxCUI
- 2204102
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2204102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Harvoni (ledipasvir 33.75 MG / sofosbuvir 150 MG) per packet Oral Pellets
Related concepts
- sofosbuvir 150 MG (SCDC, consists of)
- ledipasvir 33.75 MG (SCDC, consists of)
- ledipasvir 33.75 MG / sofosbuvir 150 MG [Harvoni] (SBDC, consists of)
- Oral Pellet (DF, has dose form)
- Harvoni (BN, has ingredient)
- ledipasvir 33.75 MG / sofosbuvir 150 MG Oral Pellet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2204102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2204102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2204102. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.